BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31186956)

  • 1. Prognostic Factors and Survival Time in Patients with Small Bowel Tumors: A Retrospective Observational Study.
    Taghipour Zahir S; Heidarymeybodi Z; AleSaeidi S
    Int J Surg Oncol; 2019; 2019():2912361. PubMed ID: 31186956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.
    Aydin D; Sendur MA; Kefeli U; Unal OU; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Ustaalioglu BB; Uysal M; Esbag O; Yazilitas D; Tanrıverdi O; Bilici A; Arpaci E; Berk V; Yetisyigit T; Ozdemir NY; Oztop I; Alacacioglu A; Aydin O; Ozcelik M; Yildirim E; Dinc N; Gumus M
    Clin Colorectal Cancer; 2017 Sep; 16(3):220-227. PubMed ID: 27670893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Small bowel tumors: experience at the Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán"].
    Sánchez-Ramón A; Cerino-Palomino V; Medina-Franco H
    Rev Gastroenterol Mex; 2012; 77(4):181-5. PubMed ID: 23177666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer.
    Young JI; Mongoue-Tchokote S; Wieghard N; Mori M; Vaccaro GM; Sheppard BC; Tsikitis VL
    Dis Colon Rectum; 2016 Apr; 59(4):306-15. PubMed ID: 26953989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors.
    Abrahams NA; Halverson A; Fazio VW; Rybicki LA; Goldblum JR
    Dis Colon Rectum; 2002 Nov; 45(11):1496-502. PubMed ID: 12432298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of, phenotypes of and survival from small bowel cancer in Denmark, 1994-2010: a population-based study.
    Bojesen RD; Andersson M; Riis LB; Nielsen OH; Jess T
    J Gastroenterol; 2016 Sep; 51(9):891-9. PubMed ID: 26847562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Factors Associated With Progression for Advanced-Stage/G1 and G2 Small-Bowel Neuroendocrine Tumors After Multimodal Therapy: Experience From a Tertiary Referral Center.
    Khetan P; Oyewole F; Wolin E; Kim MK; Divino CM
    Pancreas; 2020 Apr; 49(4):509-513. PubMed ID: 32224719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
    Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
    Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
    Ahmed A; Turner G; King B; Jones L; Culliford D; McCance D; Ardill J; Johnston BT; Poston G; Rees M; Buxton-Thomas M; Caplin M; Ramage JK
    Endocr Relat Cancer; 2009 Sep; 16(3):885-94. PubMed ID: 19458024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).
    Aydin D; Sendur MA; Kefeli U; Umut Unal O; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Bala Ustaalioglu B; Sener Dede D; Esbag O; Inal A; Bilir C; Bilici A; Harputlu H; Berk V; Sevinc A; Yildirim Ozdemir N; Yildirim E; Sonkaya A; Ali Ustaoglu M; Gumus M
    J BUON; 2016; 21(5):1242-1249. PubMed ID: 27837629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small bowel sarcoma: analysis of survival from the National Cancer Data Base.
    Howe JR; Karnell LH; Scott-Conner C
    Ann Surg Oncol; 2001 Jul; 8(6):496-508. PubMed ID: 11456049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
    Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
    J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
    Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
    Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Factors Associated with Outcomes in Small Bowel Neuroendocrine Tumors.
    Manguso N; Johnson J; Harit A; Nissen N; Mirocha J; Hendifar A; Amersi F
    Am Surg; 2017 Oct; 83(10):1174-1178. PubMed ID: 29391119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs.
    Chen L; Zhou L; Zhang M; Shang L; Zhang P; Wang W; Fang C; Li J; Xu T; Tan H; Zhang P; Qiu M; Yu X; Jin K; Chen Y; Chen H; Lin R; Zhang Q; Shen L; Chen M; Li J; Li L; Chen J
    BMC Cancer; 2017 Aug; 17(1):521. PubMed ID: 28778195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management.
    Talamonti MS; Goetz LH; Rao S; Joehl RJ
    Arch Surg; 2002 May; 137(5):564-70; discussion 570-1. PubMed ID: 11982470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.
    Massironi S; Del Gobbo A; Cavalcoli F; Fiori S; Conte D; Pellegrinelli A; Milione M; Ferrero S
    Endocrine; 2017 Nov; 58(2):360-367. PubMed ID: 28210937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology Database.
    Fisher MD; Pulgar S; Kulke MH; Mirakhur B; Miller PJ; Walker MS; Schwartzberg LS
    J Gastrointest Cancer; 2019 Dec; 50(4):816-823. PubMed ID: 30121904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence and Survival Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Small Bowel Adenocarcinoma.
    Saxena A; Valle SJ; Liauw W; Morris DL
    Anticancer Res; 2017 Oct; 37(10):5737-5742. PubMed ID: 28982894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and prognosis of malignant small bowel tumors: Experience from a university hospital in Chile.
    Silva F; Bustamante M; Latorre G; Flandez J; Montero I; Dukes E; Gandara V; Robles C; Uribe J; Iglesias A; Bellolio F; Molina ME; Migueles R; Urrejola G; Larach T; Besser N; Sharp A; Agüero C; Riquelme A; Vargas JI; Candia R; Monrroy H; De Simone F; Espino A
    Gastroenterol Hepatol; 2024 May; 47(5):491-499. PubMed ID: 38331316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.